• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

津巴布韦人群中细胞色素P450 CYP2D6的基因多态性

Genetic polymorphism of cytochrome P450 CYP2D6 in Zimbabwean population.

作者信息

Masimirembwa C M, Johansson I, Hasler J A, Ingelman-Sundberg M

机构信息

Department of Biochemistry, University of Zimbabwe, Harare.

出版信息

Pharmacogenetics. 1993 Dec;3(6):275-80. doi: 10.1097/00008571-199312000-00001.

DOI:10.1097/00008571-199312000-00001
PMID:7908586
Abstract

The objective of this study was to determine the CYP2D6 genotype of a black Zimbabwean population. Genotyping was carried out using Eco RI and Xba I RFLP, and allele-specific PCR amplification. Of 114 Zimbabwean samples analysed, no individual homozygous for any of the defect allelic forms CYP2D6A, CYP2D6B or CYP2D6D or combinations thereof was found. The allele frequencies of the three defect genes were 0, 1.8 and 3.9%, respectively. No subject carrying the Xba I 44 kb haplotype, indicative for poor metabolizers among Caucasians, was identified, whereas five individuals being heterozygous with a 29/42 kb haplotype were seen. Three out of the four CYP2D6B alleles found were associated with the 29/42 kb haplotype. Our findings are in agreement with the 0-2% prevalence of poor metabolizers (PMs) in the black populations previously phenotyped. The very low frequency of the CYP2D6B allele in the Zimbabwean population is different from very recent data from black Americans (allele frequency = 8.5%) and might indicate the Caucasian ancestry of this allele. Taken together, our data indicate important interethnic differences in the CYP2D locus between Caucasian, Asian and different black populations.

摘要

本研究的目的是确定津巴布韦黑人人群的CYP2D6基因型。使用Eco RI和Xba I限制性片段长度多态性(RFLP)以及等位基因特异性PCR扩增进行基因分型。在分析的114份津巴布韦样本中,未发现任何个体对CYP2D6A、CYP2D6B或CYP2D6D等任何缺陷等位基因形式或其组合呈纯合状态。这三个缺陷基因的等位基因频率分别为0%、1.8%和3.9%。未鉴定出携带Xba I 44 kb单倍型(在白种人中指示代谢不良者)的受试者,而观察到五名个体为29/42 kb单倍型的杂合子。所发现的四个CYP2D6B等位基因中有三个与29/42 kb单倍型相关。我们的研究结果与先前已进行表型分析的黑人人群中代谢不良者(PMs)0 - 2%的患病率一致。津巴布韦人群中CYP2D6B等位基因的极低频率与美国黑人的最新数据(等位基因频率 = 8.5%)不同,这可能表明该等位基因具有白种人血统。综上所述,我们的数据表明在白种人、亚洲人和不同黑人人群之间,CYP2D基因座存在重要的种族间差异。

相似文献

1
Genetic polymorphism of cytochrome P450 CYP2D6 in Zimbabwean population.津巴布韦人群中细胞色素P450 CYP2D6的基因多态性
Pharmacogenetics. 1993 Dec;3(6):275-80. doi: 10.1097/00008571-199312000-00001.
2
PCR-based CYP2D6 genotyping for Finnish lung cancer patients.基于聚合酶链反应的芬兰肺癌患者CYP2D6基因分型
Pharmacogenetics. 1993 Feb;3(1):19-27. doi: 10.1097/00008571-199302000-00002.
3
Analysis of the CYP2D6 gene in relation to debrisoquin and desipramine hydroxylation in a Swedish population.瑞典人群中与异喹胍和地昔帕明羟基化相关的CYP2D6基因分析。
Clin Pharmacol Ther. 1992 Jan;51(1):12-7. doi: 10.1038/clpt.1992.2.
4
Detection of the poor metabolizer-associated CYP2D6(D) gene deletion allele by long-PCR technology.采用长链聚合酶链反应技术检测与代谢不良者相关的CYP2D6(D)基因缺失等位基因。
Pharmacogenetics. 1995 Aug;5(4):215-23. doi: 10.1097/00008571-199508000-00005.
5
Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine.细胞色素P450 CYP2D基因座中一个活性基因的遗传性扩增是导致异喹胍超快代谢的原因。
Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11825-9. doi: 10.1073/pnas.90.24.11825.
6
Genetic analysis of the CYP2D locus in relation to debrisoquine hydroxylation capacity in Korean, Japanese and Chinese subjects.
Pharmacogenetics. 1995 Jun;5(3):159-64. doi: 10.1097/00008571-199506000-00004.
7
Genotyping of the CYP2D6 gene in Norwegian lung cancer patients and controls.挪威肺癌患者及对照人群中CYP2D6基因的基因分型
Pharmacogenetics. 1994 Apr;4(2):47-57.
8
Genetic basis for a lower prevalence of deficient CYP2D6 oxidative drug metabolism phenotypes in black Americans.美国黑人中细胞色素P450 2D6氧化药物代谢缺陷表型患病率较低的遗传基础。
J Clin Invest. 1993 May;91(5):2150-4. doi: 10.1172/JCI116441.
9
Debrisoquin and S-mephenytoin hydroxylation phenotypes and CYP2D6 genotypes in an Estonian population.爱沙尼亚人群中异喹胍和S-美芬妥因的羟化表型及CYP2D6基因型
Pharmacol Toxicol. 1996 May;78(5):303-7. doi: 10.1111/j.1600-0773.1996.tb01379.x.
10
Phenotypes and genotypes for CYP2D6 and CYP2C19 in a black Tanzanian population.坦桑尼亚黑人人群中CYP2D6和CYP2C19的表型和基因型
Br J Clin Pharmacol. 1999 Sep;48(3):395-401. doi: 10.1046/j.1365-2125.1999.00019.x.

引用本文的文献

1
Pharmacogenetics of Breast Cancer Treatments: A Sub-Saharan Africa Perspective.乳腺癌治疗的药物遗传学:撒哈拉以南非洲视角
Pharmgenomics Pers Med. 2022 Jun 21;15:613-652. doi: 10.2147/PGPM.S308531. eCollection 2022.
2
Effects of genetic polymorphism of drug-metabolizing enzymes on the plasma concentrations of antiepileptic drugs in Chinese population.遗传多态性对中国人群抗癫痫药物血药浓度的影响。
Bioengineered. 2022 Mar;13(3):7709-7745. doi: 10.1080/21655979.2022.2036916.
3
African variation at Cytochrome P450 genes: Evolutionary aspects and the implications for the treatment of infectious diseases.
非洲细胞色素 P450 基因的变异:进化方面及其对传染病治疗的影响。
Evol Med Public Health. 2013 Jan;2013(1):118-34. doi: 10.1093/emph/eot010. Epub 2013 May 15.
4
Risk assessment and communication tools for genotype associations with multifactorial phenotypes: the concept of "edge effect" and cultivating an ethical bridge between omics innovations and society.多因素表型的基因型关联风险评估与沟通工具:“边缘效应”概念以及搭建组学创新与社会之间的伦理桥梁
OMICS. 2009 Feb;13(1):43-61. doi: 10.1089/omi.2009.0011.
5
Halofantrine and chloroquine inhibit CYP2D6 activity in healthy Zambians.卤泛群和氯喹可抑制赞比亚健康人群的CYP2D6活性。
Br J Clin Pharmacol. 1998 Mar;45(3):315-7. doi: 10.1046/j.1365-2125.1998.00671.x.
6
Phenotypes and genotypes for CYP2D6 and CYP2C19 in a black Tanzanian population.坦桑尼亚黑人人群中CYP2D6和CYP2C19的表型和基因型
Br J Clin Pharmacol. 1999 Sep;48(3):395-401. doi: 10.1046/j.1365-2125.1999.00019.x.
7
Failure to respond to treatment with typical antipsychotics is not associated with CYP2D6 ultrarapid hydroxylation.对典型抗精神病药物治疗无反应与CYP2D6超快速羟基化无关。
Br J Clin Pharmacol. 1999 Sep;48(3):388-94. doi: 10.1046/j.1365-2125.1999.00006.x.
8
Polymorphic cytochromes P450 and drugs used in psychiatry.多态性细胞色素P450与精神科用药
Cell Mol Neurobiol. 1999 Jun;19(3):325-54. doi: 10.1023/a:1006945715127.
9
Polymorphisms of xenobiotic-metabolizing enzymes and susceptibility to cancer.异生物质代谢酶的多态性与癌症易感性
Environ Health Perspect. 1999 Feb;107 Suppl 1(Suppl 1):37-47. doi: 10.1289/ehp.99107s137.
10
CYP2D6 polymorphism in a Gabonese population: contribution of the CYP2D6*2 and CYP2D6*17 alleles to the high prevalence of the intermediate metabolic phenotype.加蓬人群中的CYP2D6基因多态性:CYP2D6*2和CYP2D6*17等位基因对中间代谢表型高患病率的影响
Br J Clin Pharmacol. 1999 Jan;47(1):121-4. doi: 10.1046/j.1365-2125.1999.00861.x.